Tag Archive for: clinical study

Invizius receives MHRA approval to commence First-in-Human clinical study of H-Guard® Priming Solution

Invizius Limited (“Invizius”), a biotechnology company developing second generation therapies for a range of complement-driven autoimmune and inflammatory disorders, is pleased to announce that it has received approval from the UK Medicines and Healthcare products Regulatory Agency (MHRA) to commence its First-in-Human clinical study of lead product, H-Guard. The study will be conducted at the […]

Versameb to Attend Biotech Showcase 2022

Versameb AG (“Versameb”), a pre-clinical stage company focused on discovering and developing innovative RNA-based therapeutics, today announces that it will be attending Biotech Showcase: The Investor Conference for Innovators on 10-12 January 2022. The Versameb team will be attending virtually. Read more…